Search   
MSDS  : 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(2- thienyl)acetamido)-, acetate, monosodium salt
CAS  : 58-71-9
SYNONYMS  : * Averon-1 * Cefalothine sodium * Cefalothin sodium * Cefalotina sodica * Cephalothin sodium * Ceporacin * Cepovenin * Chephalotin * Coaxin * Keflin * Lilly 38253 * Lospoven * Microtin * Sodium cephalothin * Synclotin * 7-(Thiophene-2-acetamido)cephalosporanic acid sodium salt * Toricelocin
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : XI0388300
CHEMICAL NAME : 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic
acid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-
thienyl)acetamido)-, acetate, monosodium salt
CAS REGISTRY NUMBER : 58-71-9
LAST UPDATED : 199609
DATA ITEMS CITED : 27
MOLECULAR FORMULA : C16-H15-N2-O6-S2.Na
MOLECULAR WEIGHT : 418.44
WISWESSER LINE NOTATION : T46 ANV ES GUTJ G1OV1 HVO CMV1- BT5SJ &-NA-
COMPOUND DESCRIPTOR : Drug
Mutagen
Human
SYNONYMS/TRADE NAMES :
* Averon-1
* Cefalothine sodium
* Cefalothin sodium
* Cefalotina sodica
* Cephalothin sodium
* Ceporacin
* Cepovenin
* Chephalotin
* Coaxin
* Keflin
* Lilly 38253
* Lospoven
* Microtin
* Sodium cephalothin
* Synclotin
* 7-(Thiophene-2-acetamido)cephalosporanic acid sodium salt
* Toricelocin

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 20 mg/kg
TOXIC EFFECTS :
Blood - thrombocytopenia
REFERENCE :
AIMEAS Annals of Internal Medicine. (American College of Physicians, 4200
Pine St., Philadelphia, PA 19104) V.1- 1927- Volume(issue)/page/year:
77,401,1972

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Human - child
DOSE/DURATION : 89 mg/kg/19D-I
TOXIC EFFECTS :
Blood - agranulocytosis
REFERENCE :
AACHAX Antimicrobial Agents and Chemotherapy (1961-70). (Ann Arbor, MI)
1961-70. For publisher information, see AMACCQ. Volume(issue)/page/year:
-,272,1963

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Human - man
DOSE/DURATION : 955 mg/kg/22D-I
TOXIC EFFECTS :
Blood - agranulocytosis
REFERENCE :
AACHAX Antimicrobial Agents and Chemotherapy (1961-70). (Ann Arbor, MI)
1961-70. For publisher information, see AMACCQ. Volume(issue)/page/year:
-,272,1963

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 27,746,1974

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 6250 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
18,185,1971

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 7500 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - acute pulmonary edema
REFERENCE :
CLMEA3 Clinical Medicine. (Northfield, IL) V.31-33, 1924-26; V.47-85,
1940-78. Volume(issue)/page/year: 70,1123,1963

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 5600 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation
Behavioral - convulsions or effect on seizure threshold
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 28,231,1975

TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >20 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 28,81,1975

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 5670 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - effect, not otherwise specified
Behavioral - convulsions or effect on seizure threshold
Skin and Appendages - hair
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 27,746,1974

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 7500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JACHDX Journal of Antimicrobial Chemotherapy. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1975- Volume(issue)/page/year:
6(Suppl A),79,1980

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 4800 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - effect, not otherwise specified
Behavioral - convulsions or effect on seizure threshold
Skin and Appendages - hair
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 27,746,1974

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AMACCQ Antimicrobial Agents and Chemotherapy. (American Soc. for
Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972-
Volume(issue)/page/year: 1,67,1972

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 6 gm/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation
Behavioral - convulsions or effect on seizure threshold
Gastrointestinal - nausea or vomiting
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 28,205,1975

TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Mammal - cat
DOSE/DURATION : >1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JIDIAQ Journal of Infectious Diseases. (Univ. of Chicago Press, Journals
Div., POB 37005, Chicago, IL 60637) V.1- 1904- Volume(issue)/page/year:
137,S51,1978

TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : >2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JIDIAQ Journal of Infectious Diseases. (Univ. of Chicago Press, Journals
Div., POB 37005, Chicago, IL 60637) V.1- 1904- Volume(issue)/page/year:
137,S51,1978

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - guinea pig
DOSE/DURATION : 110 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
CLMEA3 Clinical Medicine. (Northfield, IL) V.31-33, 1924-26; V.47-85,
1940-78. Volume(issue)/page/year: 70,1123,1963

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - guinea pig
DOSE/DURATION : 150 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
CLMEA3 Clinical Medicine. (Northfield, IL) V.31-33, 1924-26; V.47-85,
1940-78. Volume(issue)/page/year: 70,1123,1963

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 96 gm/kg/30D-I
TOXIC EFFECTS :
Liver - changes in liver weight
Endocrine - changes in adrenal weight
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - phosphatases
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 27,746,1974

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 78 gm/kg/26W-I
TOXIC EFFECTS :
Blood - other changes
Nutritional and Gross Metabolic - weight loss or decreased weight gain
Related to Chronic Data - death
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 28,195,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 63 gm/kg/21D-I
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - respiratory stimulation
Kidney, Ureter, Bladder - changes in bladder weight
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
26(Suppl 1),185,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 72900 mg/kg/31D-I
TOXIC EFFECTS :
Gastrointestinal - other changes
Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - transaminases
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 28,231,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 48 gm/kg/30D-I
TOXIC EFFECTS :
Endocrine - changes in thyroid weight
Blood - changes in erythrocyte (RBC) count
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - transaminases
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 27,746,1974

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 52 gm/kg/30D-I
TOXIC EFFECTS :
Gastrointestinal - nausea or vomiting
Liver - other changes
Kidney, Ureter, Bladder - changes in tubules (including acute renal failure,
acute tubular necrosis)
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 28,205,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 15 gm/kg/10D-I
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation
Gastrointestinal - changes in structure or function of salivary glands
Gastrointestinal - nausea or vomiting
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 28,205,1975

*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***

NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOHS - National Occupational Hazard Survey (1974)
NOHS Hazard Code - 83944
No. of Facilities: 33 (estimated)
No. of Industries: 1
No. of Occupations: 1
No. of Employees: 1650 (estimated)

NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - 83944
No. of Facilities: 620 (estimated)
No. of Industries: 1
No. of Occupations: 11
No. of Employees: 22644 (estimated)
No. of Female Employees: 18457 (estimated)

*** STATUS IN U.S. ***

EPA GENETOX PROGRAM 1988, Negative: E coli polA without S9


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
5-Thia-1-azabicyclo(4,2,0)oct-2-ene-2-carboxylicacid, 3-(hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-, acetate (ester), monosodiumsalt 24356-60-3
2-Thenylamine, N,N-bis(2-chloroethyl)-5-methyl- 3331-95-1
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, acetate (ester) 153-61-7
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, acetate, monosodium salt 58-71-9
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, sodium salt 5547-29-5
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((((4-hydroxy-6-methyl-3-pyridinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-t etrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt,(6R-(6-alpha,7-beta(R*)))- 74849-93-7
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-((hydroxyphenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-,(6R-(6-alpha,7-beta(R*)))- 34444-01-4
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid,7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-sulfomethyl)-1H-tetrazol-5-yl) thio)methyl)-,(6R-(6-alpha,7-beta(R*)))- 61270-58-4
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((((5-hydroxy-2-(1-piperazinyl)pyrido(2,3-d)pyrimidin-6-yl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)- 3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt,(6R-(6-alpha,7-beta(R*)))- 60837-22-1
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-((((1-imino-2-phenylethyl)amino)acetyl)amino)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-, (6R-trans)- 40158-24-5
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodiumsalt, D- 30034-03-8
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(4-methoxyphenyl)cyclopentyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)- 108098-26-6
2-Thenylamine, N,N-bis(2-chloroethyl)-5-methyl-,hydrochloride 14742-54-2
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(3-methoxyphenyl)cyclopropyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)- 108098-17-5
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(4-methoxyphenyl)cyclopropyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)- 108098-18-6
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-methyl-8-oxo-7-(((1-phenylcyclopentyl)carbonyl)amino)-,(6R-trans)- 108098-25-5
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-methyl-8-oxo-7-(((1-phenylcyclopropyl)carbonyl)amino)-,(6R-trans)- 108098-16-4
5-Thia-1-azabicyclo(4,2,0)oct-2-ene-2-carboxylicacid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-(6R,7R)-7-(2-(3,5-dichloro-4-oxo-1(4H)-pyridyl)acetamid o)-, monosodium salt 63521-15-3
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)- 25953-19-9
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-, mixed with sodium nitrite (1:4) 25953-19-9
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-, (6R-trans)-, sodium salt 27164-46-1
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 8-oxo-7-((1H-tetrazol-1-ylacetyl)amino)-3-((1,3,4-thiadiazol-2-ylthio)methyl)-,monosodium salt, (6R-trans)- 41136-22-5
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(4-propoxyphenyl)cyclobutyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)- 108098-22-2
Tetrodotoxin, O(sup 4)-methyl- 7724-39-2
2-Thenylamine, alpha-(p-bromobenzyl)-, hydrochloride 80154-75-2
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(2-propoxyphenyl)cyclopentyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)- 108098-30-2
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(3-propoxyphenyl)cyclopentyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)- 108098-29-9
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(4-propoxyphenyl)cyclopentyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)- 108098-28-8
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(2-propoxyphenyl)cyclopropyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)- 108098-20-0
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(4-propoxyphenyl)cyclopropyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)- 108146-11-8
1-Thia-3-aza-2-silacyclopentane,2-(p-chlorophenyl)-2,5-diphenyl- 102367-62-4
1-Thia-3-aza-2-silacyclopentane,2-(p-chlorophenyl)-2-methyl- 84260-43-5
1-Thia-3-aza-2-silacyclopentane, 2,2-diethyl- 84260-21-9
1-Thia-3-aza-2-silacyclopentane,2,2-diethyl-5-methyl- 84260-33-3
1-Thia-3-aza-2-silacylcopentane, 2,2-dimethyl- 84260-28-6
2-Thenylamine, alpha-(p-bromobenzyl)-N-isopropyl-,hydrochloride 80154-76-3
1-Thia-3-aza-2-silacyclopentane,2,5-dimethyl-2-(p-fluorophenyl)- 84260-41-3
1-Thia-3-aza-2-silacyclopentane,2,5-dimethyl-2-(p-methoxyphenyl)- 84260-39-9
1-Thia-3-aza-2-silacyclopentane,2,5-dimethyl-2-phenyl- 84260-31-1
1-Thia-3-aza-2-silacyclopentane, 2,2-diphenyl- 84260-35-5
1-Thia-3-aza-2-silacyclopentane,2-(p-fluorophenyl)-2-methyl- 84260-27-5
1-Thia-3-aza-2-silacyclopentane,2-(p-methoxyphenyl)-2-methyl- 84260-25-3
1-Thia-3-aza-2-silacyclopentane, 2-methyl-2-phenyl- 84260-23-1
1-Thia-3-aza-2-silacyclopentane,2-methyl-2-(p-tolyl)- 84260-37-7
1-Thia-4-azaspiro(4.5)decane, 8-methyl-,hydrochloride 31404-04-3
2-Thia-7-azaspiro(4.4)nonane-6,8-dione, 7-allyl- 10288-31-0
3-Thenylamine, 2-bromo-N,N-bis(2-chloroethyl)-,hydrochloride 13792-99-9
7-Thiabicyclo(2.2.1)heptane-2,3-dicarboxylic acid,(exo,exo)- 109282-39-5
9-Thiabicyclo(3.3.1)nonane, 2,6-dichloro- 6522-21-0
8-Thia-1,3-diazaspiro(4.5)decane-2,4-dione 39124-15-7

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net